<?xml version="1.0"?>
<Articles JournalTitle="Case Reports in Clinical Practice">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Case Reports in Clinical Practice</JournalTitle>
      <Issn>2538-2683</Issn>
      <Volume>7</Volume>
      <Issue>5</Issue>
      <PubDate PubStatus="epublish">
        <Year>2023</Year>
        <Month>02</Month>
        <Day>19</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Isolated Painful Oculomotor Nerve Palsy as a Rare Complication of the Sinopharm COVID-19 Vaccine: A Case Report and Review of the Literature</title>
    <FirstPage>253</FirstPage>
    <LastPage>256</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Sepideh</FirstName>
        <LastName>Paybast</LastName>
        <affiliation locale="en_US">Multiple Sclerosis Research Center, Neuroscience Institute,Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Abdorreza</FirstName>
        <LastName>Naser Moghadasi</LastName>
        <affiliation locale="en_US">Multiple Sclerosis Research Center, Neuroscience Institute,Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>04</Month>
        <Day>20</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2022</Year>
        <Month>06</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">There are limited reports of oculomotor nerve palsy following vaccination. Herein, we aimed to report a case of acute oculomotor nerve palsy following the first dose of the Sinopharm vaccine. A 17-year-old woman presented with a history of acute painful diplopia and right ptosis within a week after receiving the first dosage of the Sinopharm vaccine. The neurological examination was compatible with acute right third nerve palsy sparing pupils. All the para-clinical tests were unremarkable. With a diagnosis of possible oculomotor nerve palsy as an adverse event of the COVID-19 vaccine, she was treated with steroids leading to a significant recovery. We reported the first case of acute oculomotor nerve palsy associated with the Sinopharm vaccine. However, our findings dose not conclude a causal association between oculomotor nerve palsy and COVID-19 vaccination.</abstract>
    <web_url>https://crcp.tums.ac.ir/index.php/crcp/article/view/680</web_url>
  </Article>
</Articles>
